Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

PPARgamma agonists as new therapeutic agents for the treatment of Alzheimer's disease.

Landreth G.

Exp Neurol. 2006 Jun;199(2):245-8. Epub 2006 May 30. Review. No abstract available.

PMID:
16733054
2.

Therapeutic use of agonists of the nuclear receptor PPARgamma in Alzheimer's disease.

Landreth G.

Curr Alzheimer Res. 2007 Apr;4(2):159-64. Review.

PMID:
17430241
3.

The role of tumor necrosis factor-alpha in cognitive improvement after peroxisome proliferator-activator receptor gamma agonist pioglitazone treatment in Alzheimer's disease.

Hanyu H, Sato T, Sakurai H, Iwamoto T.

J Am Geriatr Soc. 2010 May;58(5):1000-1. doi: 10.1111/j.1532-5415.2010.02841.x. No abstract available.

PMID:
20722838
4.

[Alzheimer's disease].

Hanyu H, Sato T.

Nihon Rinsho. 2010 Feb;68(2):330-4. Review. Japanese.

PMID:
20158105
5.

Importance of peroxisome proliferator-activated receptor-gamma in hepatic ischemia/reperfusion injury in mice.

Akahori T, Sho M, Hamada K, Suzaki Y, Kuzumoto Y, Nomi T, Nakamura S, Enomoto K, Kanehiro H, Nakajima Y.

J Hepatol. 2007 Dec;47(6):784-92. Epub 2007 Oct 4.

PMID:
17936399
6.

Rosiglitazone reverses memory decline and hippocampal glucocorticoid receptor down-regulation in an Alzheimer's disease mouse model.

Escribano L, Simón AM, Pérez-Mediavilla A, Salazar-Colocho P, Del Río J, Frechilla D.

Biochem Biophys Res Commun. 2009 Feb 6;379(2):406-10. doi: 10.1016/j.bbrc.2008.12.071. Epub 2008 Dec 25.

PMID:
19109927
7.

The peroxisome proliferators activated receptor-gamma agonists as therapeutics for the treatment of Alzheimer's disease and mild-to-moderate Alzheimer's disease: a meta-analysis.

Cheng H, Shang Y, Jiang L, Shi TL, Wang L.

Int J Neurosci. 2016;126(4):299-307. doi: 10.3109/00207454.2015.1015722. Epub 2015 May 22.

PMID:
26001206
8.

Peroxisome proliferator-activated receptor gamma as a novel therapeutic target in asthma.

Park SJ, Lee YC.

J Asthma. 2008 Jan-Feb;45(1):1-8. doi: 10.1080/02770900701247319. Review.

PMID:
18259989
9.

[The peroxisome-proliferator-activated gamma receptor and chronic inflammatory bowel disease (PPARgamma and IBD)].

Rousseaux C, Desreumaux P.

J Soc Biol. 2006;200(2):121-31. Review. French.

PMID:
17151549
10.
11.

PPARgamma as a therapeutic target in central nervous system diseases.

Sundararajan S, Jiang Q, Heneka M, Landreth G.

Neurochem Int. 2006 Jul;49(2):136-44. Epub 2006 Jun 12. Review.

PMID:
16766086
12.

Drug insight: effects mediated by peroxisome proliferator-activated receptor-gamma in CNS disorders.

Heneka MT, Landreth GE, Hüll M.

Nat Clin Pract Neurol. 2007 Sep;3(9):496-504. Review.

PMID:
17805244
13.

Peroxisome proliferator-activated receptor gamma regulates E-cadherin expression and inhibits growth and invasion of prostate cancer.

Annicotte JS, Iankova I, Miard S, Fritz V, Sarruf D, Abella A, Berthe ML, Noël D, Pillon A, Iborra F, Dubus P, Maudelonde T, Culine S, Fajas L.

Mol Cell Biol. 2006 Oct;26(20):7561-74.

14.

Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist.

Nicolakakis N, Aboulkassim T, Ongali B, Lecrux C, Fernandes P, Rosa-Neto P, Tong XK, Hamel E.

J Neurosci. 2008 Sep 10;28(37):9287-96. doi: 10.1523/JNEUROSCI.3348-08.2008.

15.

Molecular mechanism of PPAR in the regulation of age-related inflammation.

Chung JH, Seo AY, Chung SW, Kim MK, Leeuwenburgh C, Yu BP, Chung HY.

Ageing Res Rev. 2008 Apr;7(2):126-36. doi: 10.1016/j.arr.2008.01.001. Epub 2008 Jan 19. Review.

PMID:
18313368
16.
17.

Anti-inflammatory effects of PPAR-gamma agonists directly correlate with PPAR-gamma expression during acute pancreatitis.

Rollins MD, Sudarshan S, Firpo MA, Etherington BH, Hart BJ, Jackson HH, Jackson JD, Emerson LL, Yang DT, Mulvihill SJ, Glasgow RE.

J Gastrointest Surg. 2006 Sep-Oct;10(8):1120-30.

PMID:
16966031
18.

Rosiglitazone induces mitochondrial biogenesis in mouse brain.

Strum JC, Shehee R, Virley D, Richardson J, Mattie M, Selley P, Ghosh S, Nock C, Saunders A, Roses A.

J Alzheimers Dis. 2007 Mar;11(1):45-51.

PMID:
17361034
19.

Effects of PPAR gamma agonists on cardiovascular function in obese, non-diabetic patients.

Panunti B, Fonseca V.

Vascul Pharmacol. 2006 Jul;45(1):29-35. Epub 2006 Jun 14. Review.

PMID:
16777491
20.

Supplemental Content

Support Center